XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue Recognition (Tables)
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table represents Evolent’s revenue disaggregated by end-market and product type (in thousands):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2024202320242023
Medicaid$217,068 $209,318 $432,192 $392,352 
Medicare268,673 138,700 555,633 266,369 
Commercial and other161,404 121,118 298,973 238,105 
Total$647,145 $469,136 $1,286,798 $896,826 
Performance Suite$461,602 $276,576 $909,820 $516,449 
Specialty Technology and Services Suite81,515 77,052 170,518 142,368 
Administrative Services60,770 77,754 119,339 160,821 
Cases43,258 37,754 87,121 77,188 
Total$647,145 $469,136 $1,286,798 $896,826 
Schedule of Contract with Customer, Asset and Liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of June 30, 2024 and December 31, 2023 (in thousands):
June 30, 2024December 31, 2023
Short-term receivables (1)
$372,361 $446,220 
Short-term deferred revenue4,558 5,976 
Long-term deferred revenue586 1,173 
————————
(1)Excludes pharmacy rebate receivable and pharmacy claims receivable.
Changes in deferred revenue for the six months ended June 30, 2024 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$7,149 
Reclassification to revenue, as a result of performance obligations satisfied(4,259)
Cash received in advance of satisfaction of performance obligations2,254 
Balance as of end of period$5,144